![Paul Brannelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Brannelly
Plus aucun poste en cours
Profil
Paul Brannelly held several Vice President and Chief Financial Officer positions in various pharmaceutical and biotech companies such as Dyax Corp., Sirtris Pharmaceuticals, Inc., CombinatoRx, Inc., Collegium Pharmaceutical, Inc., Longwood Fund LP, Karyopharm Therapeutics, Inc., and Verastem, Inc. He also served as the Chief Financial Officer of OvaScience, Inc. Brannelly earned his undergraduate degree from the University of Massachusetts in 1995.
Anciens postes connus de Paul Brannelly
| Sociétés | Poste | Fin |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Directeur Financier/CFO | 24/05/2021 |
| KARYOPHARM THERAPEUTICS INC. | Directeur Financier/CFO | 07/08/2014 |
| VERASTEM, INC. | Directeur Financier/CFO | 06/04/2012 |
Longwood Fund LP
 Longwood Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Directeur Financier/CFO | 01/08/2011 |
Sirtris Pharmaceuticals, Inc.
 Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals | Directeur Financier/CFO | 01/09/2009 |
Formation de Paul Brannelly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals | Health Technology |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Longwood Fund LP
Longwood Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Health Technology |
Choisissez Zonebourse 
